Press release
Oncolytic Adenovirus Market was valued at USD 115 million in 2024 and is projected to reach USD 310 million by 2034
Oncolytic Adenovirus Market
The Oncolytic Adenovirus Market was valued at USD 115 million in 2024 and is projected to reach USD 310 million by 2034, growing at a CAGR of around 10.4%. Growth is driven by rising demand for gene-modified viral therapies, increasing investment in immuno-oncology, and strong clinical interest in next-generation oncolytic vectors.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71266
Key Market Drivers
• Expanding pipeline of genetically engineered oncolytic adenoviruses for solid tumors.
• Growing integration of viral therapy + immunotherapy combinations.
• Rising incidence of hard-to-treat cancers (glioma, pancreatic, melanoma).
• Increasing clinical trial funding in virotherapy and tumor-selective viral engineering.
Challenges
• Safety and manufacturing complexities of viral therapies.
• High development costs and stringent regulatory pathways.
• Limited commercialized products and small patient population.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71266/oncolytic-adenovirus-market
Market Segmentation
By Application
• Solid tumors (primary segment)
• Hematologic cancers (emerging)
By Therapy Type
• Genetically modified oncolytic adenoviruses
• Non-modified adenoviral vectors
By End User
• Hospitals
• Cancer specialty centers
• Research & clinical trial institutes
By Distribution Channel
• Hospital pharmacies
• Research supply networks
Regional Snapshot
• North America leads due to strong clinical trial activity and advanced immuno-oncology infrastructure.
• Europe shows solid growth supported by government-funded virotherapy research.
• Asia-Pacific is the fastest-growing region with rising biotech investment and expanding oncology programs.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71266
Key Companies
Oncorus, DNAtrix, Sorrento Therapeutics, Lokon Pharma, VCN Biosciences, CG Oncology, Merck (collaborative immuno-oncology programs).
Future Outlook
The market will accelerate as next-gen adenoviral vectors, combination therapies, and personalized viral platforms gain regulatory traction. Increased R&D, better tumor-targeting mechanisms, and scalable viral manufacturing will shape long-term growth.
This report is also available in the following languages : Japanese (腫瘍溶解性アデノウイルス市場), Korean (종양용해성 아데노바이러스 시장), Chinese (溶瘤腺病毒市场), French (Marché des adénovirus oncolytiques), German (Markt für onkolytische Adenoviren), and Italian (Mercato dell'adenovirus oncolitico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71266
Our More Reports:
Sarcoidosis Market
https://exactitudeconsultancy.com/reports/71350/sarcoidosis-market
Anti-Glomerular Basement Membrane Market
https://exactitudeconsultancy.com/reports/71352/anti-glomerular-basement-membrane-market
Peanut Allergy Market
https://exactitudeconsultancy.com/reports/71354/peanut-allergy-market
Cytomegalovirus (CMV) Infections Market
https://exactitudeconsultancy.com/reports/71356/cytomegalovirus-cmv-infections-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Adenovirus Market was valued at USD 115 million in 2024 and is projected to reach USD 310 million by 2034 here
News-ID: 4311333 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Oncolytic
Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth?
The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering…
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer.
Download Report:
https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas
The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take…
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy.
New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate…
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Oncolytic Virus Competitive Landscape Report
• DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…
